Monitoring of serum aminoglycoside levels with once-daily dosing

Pathology

Volumn 30, Issue 3, 1998, Pages 289-294

  Paterson, David L ^a,b   Robson, Jennifer M B ^a   Wagener, Marilyn M ^b   Peters, Michael ^a  

^a SULLIVAN NICOLAIDES PATHOLOGY   (Australia)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Aminoglycosides; Gentamicin; Monitoring; Pharmacokinetics; Tobramycin

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; TOBRAMYCIN;

ADULT; AGED; ARTICLE; AUSTRALIA; DRUG BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRACTICE GUIDELINE; PROSPECTIVE STUDY;

EID: 0031658538     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313029800169466     Document Type: Article

References (18)

1. Barza M, Ioannidis JPA, Cappelleri JC, Lau J. Single or multiple daily doses of aminoglycosides: a meta-analysis. Br Med J 1996; 312: 338-45.
2. Hatala R, Dinh T, Cook DJ. Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis. Ann Intern Med 1996; 124: 717-25.
3. Munckhof WJ, Grayson ML, Turnidge JD. A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother 1996; 37: 645-63.
4. Begg EJ, Barclay ML, Duffull SB. A suggested approach to once-daily aminoglycoside dosing. Br J Clin Pharmac 1995; 39: 605-9.
5. Cronberg S. Simplified monitoring of aminoglycosides. J Antimicrob Chemother 1994; 34: 819-27.
6. Konrad F, Wagner R, Neumeister B, Rommel H, Georgieff M. Studies on drug monitoring in three and once-daily treatment with aminoglycosides. Intensive Care Med 1993; 19: 215-20.
7. Turnidge J, Bell J, Mascaro L. The peak-AUC method for aminoglycoside dosage adjustment. Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, September 1996.
8. Victorian Drug Usage Advisory Committee, Antibiotic guidelines. 9th edn. North Melbourne: Victorian Medical Postgraduate Foundation Inc., 1996.
9. Smith CR, Lipsky JJ, Laskin OL, Hellmann DB, Mellits ED, Longstreth J, et al. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med 1980; 302: 1106-9.
10. Longridge NS. Approach to the patient with dizziness and vertigo. In: Kelley WN, editor. Textbook of Internal Medicine. 3rd edn. Philadelphia: Lippincott-Raven, 1997.
11. Blaser J, Konig C. Once-daily dosing of aminoglycosides. Eur J Clin Microbiol Infect Dis 1995; 14: 1029-38.
12. Prins JM, Weverling GJ, De Blok K, Van Ketel RJ, Speelman P. Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy. Antimicrob Agents Chemother 1996; 40: 2494-9.
13. Koo J, Tight R, Rajkumar V, Hawa Z. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients. Am J Med 1996; 101: 177-83.
14. McCormack JP, Jewesson PJ. A critical reevaluation of the "therapeutic range" of aminoglycosides. Clin Infect Dis 1992; 14: 320-9.
15. Brown G, McCormack JP. Studies on drug monitoring in thrice and once daily treatment with aminoglycosides. Intensive Care Med 1993; 20: 243-4.
16. Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R. Experience with a once-daily aminoglycoside program administered to 2184 adult patients. Antimicrob Agents Chemother 1995; 39: 650-5.
17. Nicolau DP, WU AHB, Finocchiaro S, Udeh E, Chow MSS, Quintiliani R, Nightingale CH. Once-daily aminoglycoside dosing: impact on requests and costs for therapeutic drug monitoring. Ther Drug Monitor 1996; 18: 263-6.
18. Moore RD, Smith CR, Lietman PS. Association of aminoglycoside plasma levels with therapeutic outcome in Gram-negative pneumonia. Am J Med 1984; 77: 657-62.